Chinese Journal of Dermatology ›› 2020, Vol. 53 ›› Issue (3): 214-219.doi: 10.35541/cjd.20190789
• Original Articles • Previous Articles Next Articles
Liu Wan, Wu Yatong, Gao Xiaoman, Yang Min, Bao Yingqiu, Fu Yu, Chang Jianmin
Received:
2019-08-01
Revised:
2019-12-19
Online:
2020-03-15
Published:
2020-03-03
Contact:
Chang Jianmin
E-mail:changjm0417@126.com
Supported by:
Liu Wan, Wu Yatong, Gao Xiaoman, Yang Min, Bao Yingqiu, Fu Yu, Chang Jianmin. Analysis of factors associated with skin lesion distribution in 1 125 patients with non-segmental vitiligo[J]. Chinese Journal of Dermatology, 2020, 53(3): 214-219.doi:10.35541/cjd.20190789
[1] | Alkhateeb A, Fain PR, Thody A, et al. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families[J]. Pigment Cell Res, 2003,16(3):208⁃214. doi: 10.1034/j.1600⁃0749.2003.00032.x. |
[2] | Bhandarkar SS, Kundu RV. Quality⁃of⁃life issues in vitiligo[J]. Dermatol Clin, 2012,30(2):255⁃268, viii. doi: 10.1016/j.det.2011. 11.013. |
[3] | Yaghoobi R, Omidian M, Bagherani N. Vitiligo: a review of the published work[J]. J Dermatol, 2011,38(5):419⁃431. doi: 10. 1111/j.1346⁃8138.2010.01139.x. |
[4] | 许爱娥. 白癜风发病机制及治疗靶点的研究现状[J]. 中华皮肤科杂志, 2016,49(6):377⁃379. doi: 10.3760/cma.j.issn.0412⁃4030.2016.06.001. |
[5] | 李春英, 李舒丽. 白癜风发病机制研究热点解析[J]. 中华皮肤科杂志, 2019,52(9):593⁃597. doi: 10.3760/cma.j.issn.0412⁃4030.2019.09.001. |
[6] | Silverberg JI, Silverberg NB. Clinical features of vitiligo associated with comorbid autoimmune disease: a prospective survey[J]. J Am Acad Dermatol, 2013,69(5):824⁃826. doi: 10. 1016/j.jaad.2013.04.050. |
[7] | Kanwar AJ, Mahajan R, Parsad D. Effect of age at onset on disease characteristics in vitiligo[J]. J Cutan Med Surg, 2013,17(4):253⁃258. doi: 10.2310/7750.2013.12075. |
[8] | Speeckaert R, van Geel N. Distribution patterns in generalized vitiligo[J]. J Eur Acad Dermatol Venereol, 2014,28(6):755⁃762. doi: 10.1111/jdv.12171. |
[9] | van Geel N, Speeckaert R, De Wolf J, et al. Clinical significance of Koebner phenomenon in vitiligo[J]. Br J Dermatol, 2012,167(5):1017⁃1024. doi: 10.1111/j.1365⁃2133.2012.11158.x. |
[10] | van Geel N, Speeckaert M, Brochez L, et al. Clinical profile of generalized vitiligo patients with associated autoimmune/autoinflammatory diseases[J]. J Eur Acad Dermatol Venereol, 2014,28(6):741⁃746. doi: 10.1111/jdv.12169. |
[11] | Spritz RA. Six decades of vitiligo genetics: genome⁃wide studies provide insights into autoimmune pathogenesis[J]. J Invest Dermatol, 2012,132(2):268⁃273. doi: 10.1038/jid.2011.321. |
[12] | LaBerge GS, Bennett DC, Fain PR, et al. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not[J]. J Invest Dermatol, 2008,128(7):1757⁃1762. doi: 10.1038/sj.jid. 5701233. |
[13] | D′Osualdo A, Reed JC. NLRP1, a regulator of innate immunity associated with vitiligo[J]. Pigment Cell Melanoma Res, 2012,25(1):5⁃8. doi: 10.1111/j.1755⁃148X.2011.00942.x. |
[14] | Birlea SA, Laberge GS, Procopciuc LM, et al. CTLA4 and generalized vitiligo: two genetic association studies and a meta⁃analysis of published data[J]. Pigment Cell Melanoma Res, 2009,22(2):230⁃234. doi: 10.1111/j.1755⁃148X.2009.00543.x. |
[15] | Carvalho CL, Ortigosa LC. Segmental vitiligo after infliximab use for rheumatoid arthritis⁃⁃a case report[J]. An Bras Dermatol, 2014,89(1):154⁃156. doi: 10.1590/abd1806⁃4841.20142887. |
[16] | Maruthappu T, Leandro M, Morris SD. Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab[J]. Dermatol Ther, 2013,26(4):370⁃372. doi: 10. 1111/dth.12002. |
[17] | Karelson M, Silm H, Salum T, et al. Differences between familial and sporadic cases of vitiligo[J]. J Eur Acad Dermatol Venereol, 2012,26(7):915⁃918. doi: 10.1111/j.1468⁃3083.2011.04131.x. |
[1] | Lei Jiehao, Hong Weisong, Lin Fuquan, Hu Wenting, Xu Ai′e. In vitro culture of melanocytes from segmental vitiligo-like nevus depigmentosus lesions and its clinical significance [J]. Chinese Journal of Dermatology, 2022, 55(9): 798-802. |
[2] | Li Baizhang, Kang Pan, Zhang Xiaoying, Zhu Guannan, Li Shuli, Li Chunying. Construction and validation of a risk prediction model for diabetes mellitus in patients with vitiligo [J]. Chinese Journal of Dermatology, 2022, 55(7): 576-582. |
[3] | Jian Zhe, Zhang Jia. Research progress and thinking in mouse models of vitiligo-like depigmentation [J]. Chinese Journal of Dermatology, 2022, 55(7): 622-628. |
[4] | Committee on Autoimmune Diseases, China Dermatologist Association. Cyclosporine in the treatment of immune-related skin diseases: an expert proposal [J]. Chinese Journal of Dermatology, 2022, 55(6): 471-479. |
[5] | Shan Ying, Zuo Yagang. Correlation between autoimmune bullous diseases and psoriasis [J]. Chinese Journal of Dermatology, 2022, 55(5): 452-455. |
[6] | Ainiwaer·Talifu, Xiong Cheng, Refuhati·Saimaiti, Yusufu·Maitinuer, Tuerxun·Wufuer, Akenmujiang·Aierken, Julaiti·Abuduwayiti, Maimaitiaili·Kade. Screening and analysis of differentially expressed genes in vitiligo using bioinformatics methods [J]. Chinese Journal of Dermatology, 2022, 55(5): 421-425. |
[7] | Fu Chao, Wu Jiaona, Lang Wenchao, Gao Fei, Niu Guiye, Bian Peiwen, Gao Minhong, Si Xiaoqing, Xin Linlin. Role of dermoscopy in assessing vitiligo activity [J]. Chinese Journal of Dermatology, 2022, 55(3): 268-271. |
[8] | Zha Zhen, Solang Quzong, Ciren Yangji, Bai Yang, Deji Yangzong, Zhang Wei, . Clinical characteristics of 527 patients of Tibetan nationality with vitiligo [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210940-e20210940. |
[9] | Zeng Rui, Xu Xiulian. Narrow-band ultraviolet B phototherapy combined with other therapies for the treatment of vitiligo [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210010-e20210010. |
[10] | Luan Chao, Hu Yu, Chen Kun, Zhang Jiaan, Gu Heng, Zhang Ronglin, Zhang Xiaohua, Tian Panpan, Zhu Yan, Zhuang Chen, Huang Dan, Ju Mei. Efficacy and safety of 308-nm SQ light-emitting diode light and 308-nm excimer light in the treatment of facial vitiligo: a retrospective study [J]. Chinese Journal of Dermatology, 2022, 55(1): 16-19. |
[11] | Chen Yi, Song Xiuzu. Role of transient receptor potential channels in melanocytes and their related diseases [J]. Chinese Journal of Dermatology, 2022, 0(1): 20200958-e20200958. |
[12] | Guo Lifang, Ge Yiping, Yang Yin, Lin Tong. Establishment and evaluation of an artificial intelligence model for the diagnosis of facial vitiligo [J]. Chinese Journal of Dermatology, 2021, 54(7): 586-589. |
[13] | Ying Jieya, Xiang Wenzhong, Song Xiuzu. Metabolic syndrome and skin diseases [J]. Chinese Journal of Dermatology, 2021, 54(7): 642-645. |
[14] | Liang Gaopeng, Song Zhiqiang. Role of immunoglobulin E autoantibodies in autoimmune skin diseases [J]. Chinese Journal of Dermatology, 2021, 54(6): 553-556. |
[15] | Liao Zhikai, Lei Tiechi. Therapeutic trauma-induced repigmentation of vitiligo lesions: mechanisms and relevant clinical studies [J]. Chinese Journal of Dermatology, 2021, 54(3): 267-269. |
|